The in vitro antiproliferative efficacy of five common sigma ligands was investigated in the same panel of the 23 human established cancer cell lines in which we earlier investigated the expression levels of σ1, PGRMC1, and σ2/TMEM97 receptors. Here, PGRMC1 is linked to cancer.